Viatris Inc. (VTRS) Financials
VTRS Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 36.8 billion | 22.2 billion |
| Dec. 31, 2025 | 37.2 billion | 22.5 billion |
| Sept. 30, 2025 | 37.9 billion | 22.7 billion |
| June 30, 2025 | 38.4 billion | 22.8 billion |
VTRS Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | 348.4 million | ? |
| Dec. 31, 2025 | 550.5 million | 49.4 million |
| Sept. 30, 2025 | 645.2 million | 36.0 million |
| June 30, 2025 | 165.6 million | 37.1 million |
VTRS Net Income
| Date | Net Income |
|---|---|
| March 31, 2026 | 176.4 million |
| Dec. 31, 2025 | -340.1 million |
| Sept. 30, 2025 | -128.2 million |
| June 30, 2025 | -4.6 million |
VTRS Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 1.8 billion | 12.4 billion | - |
| Dec. 31, 2025 | 1.5 billion | 12.5 billion | 178.1 million |
| Sept. 30, 2025 | 1.2 billion | 12.5 billion | 283.3 million |
| June 30, 2025 | 808.6 million | 12.8 billion | 293.6 million |
VTRS Shares Outstanding
VTRS Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 39.9 million | 248.6 million | 928.8 million | - |
| Dec. 31, 2025 | 265.3 million | 274.7 million | 1.0 billion | - |
| Sept. 30, 2025 | 99.7 million | 250.4 million | 882.9 million | - |
| June 30, 2025 | 54.1 million | 218.8 million | 928.7 million | - |
VTRS Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 3.5 billion | 2.4 billion |
| Dec. 31, 2025 | 3.7 billion | 2.6 billion |
| Sept. 30, 2025 | 3.8 billion | 2.4 billion |
| June 30, 2025 | 3.6 billion | 2.2 billion |
VTRS Revenue by Segment
VTRS
Price: $17.22
Dividend Yield: 2.87%
Forward Dividend Yield: 2.73%
Payout Ratio: -88.89%
Dividend Per Share: 0.48 USD
Earnings Per Share: -0.30 USD
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 6.2 million
Market Capitalization: 19.4 billion
Average Dividend Frequency: 4
Years Paying Dividends: 6
DGR3: 1.45%